Tamio Ito

JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma

Toshihiko Wakabayashi, Atsushi Natsume, Junki Mizusawa et al. · Journal of Neuro-Oncology · 2018 · 65 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Careful Exclusion of Non-neoplastic Brain Components is Required for an Appropriate Evaluation of O6-methylguanine-DNA Methyltransferase Status in Glioma

Ken Sasai, Miho Nodagashira, Hiroshi Nishihara et al. · The American Journal of Surgical Pathology · 2008 · 62 citations

Medicine, Cancer Biology, Oncology +17

Clinicopathologic Study of Pineal Parenchymal Tumors of Intermediate Differentiation

Tamio Ito, Hiromi Kanno, Ken-ichi Sato et al. · World Neurosurgery · 2013 · 56 citations

Veterinary Medicine, Oncology, Pathology +13

Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305)

Soichiro Shibui, Yoshitaka Narita, Junki Mizusawa et al. · Cancer Chemotherapy and Pharmacology · 2012 · 31 citations

Medicine, Oncology, Pharmacotherapy +14

Assessment of the Anatomical Relationship Between the Arcuate Eminence and Superior Semicircular Canal by Computed Tomography

Yoshinobu Seo, Tamio Ito, Takehiko Sasaki et al. · Neurologia medico-chirurgica · 2007 · 28 citations · Full text

Dentistry, Oral Radiology, Applied Anatomy +6